Review



ferrostatin 1 fer 1  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    TargetMol ferrostatin 1 fer 1
    Ferrostatin 1 Fer 1, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 176 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ferrostatin 1 fer 1/product/TargetMol
    Average 95 stars, based on 176 article reviews
    ferrostatin 1 fer 1 - by Bioz Stars, 2026-05
    95/100 stars

    Images



    Similar Products

    99
    MedChemExpress ferroptosis inhibitor fer 1
    <t>FER-1</t> <t>attenuates</t> neuropathic pain and spinal ferroptosis in the SNI model. (A) Mechanical and thermal hyperalgesia were evaluated by the paw withdrawal threshold (PWT) and paw withdrawal latency (PWL) in Sham + Vehicle, SNI + Vehicle, and SNI + FER-1 groups. Behavioral tests were conducted at day 0 and on days 6, 7, 8, 9, 10, and 11 post-surgery (n = 9 per group). (B) Representative Western blot images and quantitative analysis of 4-HNE in spinal cord lysates 11 days post-SNI (n = 6 per group). (C) Representative double immunofluorescence images showing co-localization of 4-HNE (red) with the neuronal marker NeuN (green) in the spinal dorsal horn. Scale bar: 100 μm. White boxes indicate higher magnification views of representative neurons (n = 3 per group). (D-G) Representative Western blot images and quantitative analysis of ferroptosis-related proteins (ACSL4, SLC7A11 and GPX4) in the spinal cord. β-actin served as the loading control (n = 6 per group). (H–I) Biochemical quantification of Fe 2+ and MDA levels in spinal cord tissues (n = 6 per group). (J) Representative transmission electron microscopy (TEM) images and quantitative analysis of mitochondrial morphology in spinal neurons. Red arrowheads indicate classical shrunken mitochondria with increased electron density of the bilayer membrane, accompanied by decreased mitochondrial cristae and mitochondrial membrane rupture; blue arrowheads indicate reduced or vanishing cristae; and black arrowheads indicate outer mitochondrial membrane rupture. Scale bar: 500 nm (n = 3 per group). Significance was determined using one-way ANOVA or two-way ANOVA followed by Bonferroni's post-hoc tests. Data are expressed as mean ± SEM. (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001 vs. Sham + Vehicle group; # P < 0.05, ## P < 0.01, ### P < 0.001, #### P < 0.0001 vs. SNI + Vehicle group). The value of n represents the number of independent biological samples. All molecular experiments were independently repeated at least three times with consistent results.
    Ferroptosis Inhibitor Fer 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ferroptosis inhibitor fer 1/product/MedChemExpress
    Average 99 stars, based on 1 article reviews
    ferroptosis inhibitor fer 1 - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    95
    TargetMol ferrostatin 1 fer 1
    <t>FER-1</t> <t>attenuates</t> neuropathic pain and spinal ferroptosis in the SNI model. (A) Mechanical and thermal hyperalgesia were evaluated by the paw withdrawal threshold (PWT) and paw withdrawal latency (PWL) in Sham + Vehicle, SNI + Vehicle, and SNI + FER-1 groups. Behavioral tests were conducted at day 0 and on days 6, 7, 8, 9, 10, and 11 post-surgery (n = 9 per group). (B) Representative Western blot images and quantitative analysis of 4-HNE in spinal cord lysates 11 days post-SNI (n = 6 per group). (C) Representative double immunofluorescence images showing co-localization of 4-HNE (red) with the neuronal marker NeuN (green) in the spinal dorsal horn. Scale bar: 100 μm. White boxes indicate higher magnification views of representative neurons (n = 3 per group). (D-G) Representative Western blot images and quantitative analysis of ferroptosis-related proteins (ACSL4, SLC7A11 and GPX4) in the spinal cord. β-actin served as the loading control (n = 6 per group). (H–I) Biochemical quantification of Fe 2+ and MDA levels in spinal cord tissues (n = 6 per group). (J) Representative transmission electron microscopy (TEM) images and quantitative analysis of mitochondrial morphology in spinal neurons. Red arrowheads indicate classical shrunken mitochondria with increased electron density of the bilayer membrane, accompanied by decreased mitochondrial cristae and mitochondrial membrane rupture; blue arrowheads indicate reduced or vanishing cristae; and black arrowheads indicate outer mitochondrial membrane rupture. Scale bar: 500 nm (n = 3 per group). Significance was determined using one-way ANOVA or two-way ANOVA followed by Bonferroni's post-hoc tests. Data are expressed as mean ± SEM. (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001 vs. Sham + Vehicle group; # P < 0.05, ## P < 0.01, ### P < 0.001, #### P < 0.0001 vs. SNI + Vehicle group). The value of n represents the number of independent biological samples. All molecular experiments were independently repeated at least three times with consistent results.
    Ferrostatin 1 Fer 1, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ferrostatin 1 fer 1/product/TargetMol
    Average 95 stars, based on 1 article reviews
    ferrostatin 1 fer 1 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    99
    MedChemExpress fer 1 group
    <t>FER-1</t> <t>attenuates</t> neuropathic pain and spinal ferroptosis in the SNI model. (A) Mechanical and thermal hyperalgesia were evaluated by the paw withdrawal threshold (PWT) and paw withdrawal latency (PWL) in Sham + Vehicle, SNI + Vehicle, and SNI + FER-1 groups. Behavioral tests were conducted at day 0 and on days 6, 7, 8, 9, 10, and 11 post-surgery (n = 9 per group). (B) Representative Western blot images and quantitative analysis of 4-HNE in spinal cord lysates 11 days post-SNI (n = 6 per group). (C) Representative double immunofluorescence images showing co-localization of 4-HNE (red) with the neuronal marker NeuN (green) in the spinal dorsal horn. Scale bar: 100 μm. White boxes indicate higher magnification views of representative neurons (n = 3 per group). (D-G) Representative Western blot images and quantitative analysis of ferroptosis-related proteins (ACSL4, SLC7A11 and GPX4) in the spinal cord. β-actin served as the loading control (n = 6 per group). (H–I) Biochemical quantification of Fe 2+ and MDA levels in spinal cord tissues (n = 6 per group). (J) Representative transmission electron microscopy (TEM) images and quantitative analysis of mitochondrial morphology in spinal neurons. Red arrowheads indicate classical shrunken mitochondria with increased electron density of the bilayer membrane, accompanied by decreased mitochondrial cristae and mitochondrial membrane rupture; blue arrowheads indicate reduced or vanishing cristae; and black arrowheads indicate outer mitochondrial membrane rupture. Scale bar: 500 nm (n = 3 per group). Significance was determined using one-way ANOVA or two-way ANOVA followed by Bonferroni's post-hoc tests. Data are expressed as mean ± SEM. (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001 vs. Sham + Vehicle group; # P < 0.05, ## P < 0.01, ### P < 0.001, #### P < 0.0001 vs. SNI + Vehicle group). The value of n represents the number of independent biological samples. All molecular experiments were independently repeated at least three times with consistent results.
    Fer 1 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fer 1 group/product/MedChemExpress
    Average 99 stars, based on 1 article reviews
    fer 1 group - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    96
    Selleck Chemicals ferrostatin 1 fer 1
    Copper deprivation induced by SLC31A1 knockdown attenuates ferroptosis. ( A ) Cell viability of AsPC-1 cells treated with different doses of RSL3, ML162, ML210, or erastin in NC and SLC31A1 knockdown AsPC-1 cells. ( B ) Cell viability of AsPC-1 cells treated with different doses of CDDP, staurosporine, paclitaxel, bortezomib, JTC-801, or elesclomol-Cu in NC and SLC31A1 knockdown AsPC-1 cells. ( C-E ) Propidium iodide (PI) staining of NC and SLC31A1 knockdown AsPC-1 (C), MiaPaCa-2 (D), and CFPAC-1 (E) cells treated with RSL3 at the indicated concentrations in the presence or absence of ferroptosis inhibitors <t>(ferrostatin-1/Fer-1,</t> 5 μM or desferrioxamine/DFO, 20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( F ) Lipid peroxidation of NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 (0.25 μM) for 2 h. (G) Transmission electron microscopy of NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 (2.5 μM). Scale bar: 2 μm or 500 nm. ( H ) Confocal imaging of Cu-probe and Mito-tracker in the NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1. Hoechst (blue) is used as a nuclear counterstain. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. Scale bar: 2 μm. ( I ) Western blot analysis of lysates from NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1. ( J ) Cell viability of NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1, followed by treatment with different doses of RSL3 or erastin. ( K ) PI staining of NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1, followed by treatment with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( L ) Western blot analysis of lysates from SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or SLC31A1 WT or SLC31A1 M154A plasmid. ( M ) PI staining of SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or SLC31A1 WT or SLC31A1 M154A plasmid, followed by treatment with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test.
    Ferrostatin 1 Fer 1, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ferrostatin 1 fer 1/product/Selleck Chemicals
    Average 96 stars, based on 1 article reviews
    ferrostatin 1 fer 1 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    99
    MedChemExpress fer 1
    Copper deprivation induced by SLC31A1 knockdown attenuates ferroptosis. ( A ) Cell viability of AsPC-1 cells treated with different doses of RSL3, ML162, ML210, or erastin in NC and SLC31A1 knockdown AsPC-1 cells. ( B ) Cell viability of AsPC-1 cells treated with different doses of CDDP, staurosporine, paclitaxel, bortezomib, JTC-801, or elesclomol-Cu in NC and SLC31A1 knockdown AsPC-1 cells. ( C-E ) Propidium iodide (PI) staining of NC and SLC31A1 knockdown AsPC-1 (C), MiaPaCa-2 (D), and CFPAC-1 (E) cells treated with RSL3 at the indicated concentrations in the presence or absence of ferroptosis inhibitors <t>(ferrostatin-1/Fer-1,</t> 5 μM or desferrioxamine/DFO, 20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( F ) Lipid peroxidation of NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 (0.25 μM) for 2 h. (G) Transmission electron microscopy of NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 (2.5 μM). Scale bar: 2 μm or 500 nm. ( H ) Confocal imaging of Cu-probe and Mito-tracker in the NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1. Hoechst (blue) is used as a nuclear counterstain. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. Scale bar: 2 μm. ( I ) Western blot analysis of lysates from NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1. ( J ) Cell viability of NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1, followed by treatment with different doses of RSL3 or erastin. ( K ) PI staining of NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1, followed by treatment with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( L ) Western blot analysis of lysates from SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or SLC31A1 WT or SLC31A1 M154A plasmid. ( M ) PI staining of SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or SLC31A1 WT or SLC31A1 M154A plasmid, followed by treatment with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test.
    Fer 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fer 1/product/MedChemExpress
    Average 99 stars, based on 1 article reviews
    fer 1 - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress ferrostatin 1 fer 1
    Copper deprivation induced by SLC31A1 knockdown attenuates ferroptosis. ( A ) Cell viability of AsPC-1 cells treated with different doses of RSL3, ML162, ML210, or erastin in NC and SLC31A1 knockdown AsPC-1 cells. ( B ) Cell viability of AsPC-1 cells treated with different doses of CDDP, staurosporine, paclitaxel, bortezomib, JTC-801, or elesclomol-Cu in NC and SLC31A1 knockdown AsPC-1 cells. ( C-E ) Propidium iodide (PI) staining of NC and SLC31A1 knockdown AsPC-1 (C), MiaPaCa-2 (D), and CFPAC-1 (E) cells treated with RSL3 at the indicated concentrations in the presence or absence of ferroptosis inhibitors <t>(ferrostatin-1/Fer-1,</t> 5 μM or desferrioxamine/DFO, 20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( F ) Lipid peroxidation of NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 (0.25 μM) for 2 h. (G) Transmission electron microscopy of NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 (2.5 μM). Scale bar: 2 μm or 500 nm. ( H ) Confocal imaging of Cu-probe and Mito-tracker in the NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1. Hoechst (blue) is used as a nuclear counterstain. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. Scale bar: 2 μm. ( I ) Western blot analysis of lysates from NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1. ( J ) Cell viability of NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1, followed by treatment with different doses of RSL3 or erastin. ( K ) PI staining of NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1, followed by treatment with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( L ) Western blot analysis of lysates from SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or SLC31A1 WT or SLC31A1 M154A plasmid. ( M ) PI staining of SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or SLC31A1 WT or SLC31A1 M154A plasmid, followed by treatment with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test.
    Ferrostatin 1 Fer 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ferrostatin 1 fer 1/product/MedChemExpress
    Average 99 stars, based on 1 article reviews
    ferrostatin 1 fer 1 - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    Image Search Results


    FER-1 attenuates neuropathic pain and spinal ferroptosis in the SNI model. (A) Mechanical and thermal hyperalgesia were evaluated by the paw withdrawal threshold (PWT) and paw withdrawal latency (PWL) in Sham + Vehicle, SNI + Vehicle, and SNI + FER-1 groups. Behavioral tests were conducted at day 0 and on days 6, 7, 8, 9, 10, and 11 post-surgery (n = 9 per group). (B) Representative Western blot images and quantitative analysis of 4-HNE in spinal cord lysates 11 days post-SNI (n = 6 per group). (C) Representative double immunofluorescence images showing co-localization of 4-HNE (red) with the neuronal marker NeuN (green) in the spinal dorsal horn. Scale bar: 100 μm. White boxes indicate higher magnification views of representative neurons (n = 3 per group). (D-G) Representative Western blot images and quantitative analysis of ferroptosis-related proteins (ACSL4, SLC7A11 and GPX4) in the spinal cord. β-actin served as the loading control (n = 6 per group). (H–I) Biochemical quantification of Fe 2+ and MDA levels in spinal cord tissues (n = 6 per group). (J) Representative transmission electron microscopy (TEM) images and quantitative analysis of mitochondrial morphology in spinal neurons. Red arrowheads indicate classical shrunken mitochondria with increased electron density of the bilayer membrane, accompanied by decreased mitochondrial cristae and mitochondrial membrane rupture; blue arrowheads indicate reduced or vanishing cristae; and black arrowheads indicate outer mitochondrial membrane rupture. Scale bar: 500 nm (n = 3 per group). Significance was determined using one-way ANOVA or two-way ANOVA followed by Bonferroni's post-hoc tests. Data are expressed as mean ± SEM. (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001 vs. Sham + Vehicle group; # P < 0.05, ## P < 0.01, ### P < 0.001, #### P < 0.0001 vs. SNI + Vehicle group). The value of n represents the number of independent biological samples. All molecular experiments were independently repeated at least three times with consistent results.

    Journal: Redox Biology

    Article Title: A spinal USP7-Bach1 positive feedback loop drives NOX4-mediated ferroptosis in neuropathic pain

    doi: 10.1016/j.redox.2026.104153

    Figure Lengend Snippet: FER-1 attenuates neuropathic pain and spinal ferroptosis in the SNI model. (A) Mechanical and thermal hyperalgesia were evaluated by the paw withdrawal threshold (PWT) and paw withdrawal latency (PWL) in Sham + Vehicle, SNI + Vehicle, and SNI + FER-1 groups. Behavioral tests were conducted at day 0 and on days 6, 7, 8, 9, 10, and 11 post-surgery (n = 9 per group). (B) Representative Western blot images and quantitative analysis of 4-HNE in spinal cord lysates 11 days post-SNI (n = 6 per group). (C) Representative double immunofluorescence images showing co-localization of 4-HNE (red) with the neuronal marker NeuN (green) in the spinal dorsal horn. Scale bar: 100 μm. White boxes indicate higher magnification views of representative neurons (n = 3 per group). (D-G) Representative Western blot images and quantitative analysis of ferroptosis-related proteins (ACSL4, SLC7A11 and GPX4) in the spinal cord. β-actin served as the loading control (n = 6 per group). (H–I) Biochemical quantification of Fe 2+ and MDA levels in spinal cord tissues (n = 6 per group). (J) Representative transmission electron microscopy (TEM) images and quantitative analysis of mitochondrial morphology in spinal neurons. Red arrowheads indicate classical shrunken mitochondria with increased electron density of the bilayer membrane, accompanied by decreased mitochondrial cristae and mitochondrial membrane rupture; blue arrowheads indicate reduced or vanishing cristae; and black arrowheads indicate outer mitochondrial membrane rupture. Scale bar: 500 nm (n = 3 per group). Significance was determined using one-way ANOVA or two-way ANOVA followed by Bonferroni's post-hoc tests. Data are expressed as mean ± SEM. (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001 vs. Sham + Vehicle group; # P < 0.05, ## P < 0.01, ### P < 0.001, #### P < 0.0001 vs. SNI + Vehicle group). The value of n represents the number of independent biological samples. All molecular experiments were independently repeated at least three times with consistent results.

    Article Snippet: In in vivo experiments, the ferroptosis inhibitor FER-1 (10 mg/kg, i.p., Hy-100579) [ ], the Bach1 inhibitor Bach1-IN-1 (also known as HPPE, 10 mg/kg, i.g., HY-153040 , MCE, China), the NOX4 inhibitor GLX351322 (5 mg/kg, i.p., HY-100111, MCE, China), and the USP7 inhibitor P005091 (15 mg/kg, i.p., HY-15667 , MCE, China) were administered once daily for 5 consecutive days.

    Techniques: Western Blot, Immunofluorescence, Marker, Control, Transmission Assay, Electron Microscopy, Membrane

    Copper deprivation induced by SLC31A1 knockdown attenuates ferroptosis. ( A ) Cell viability of AsPC-1 cells treated with different doses of RSL3, ML162, ML210, or erastin in NC and SLC31A1 knockdown AsPC-1 cells. ( B ) Cell viability of AsPC-1 cells treated with different doses of CDDP, staurosporine, paclitaxel, bortezomib, JTC-801, or elesclomol-Cu in NC and SLC31A1 knockdown AsPC-1 cells. ( C-E ) Propidium iodide (PI) staining of NC and SLC31A1 knockdown AsPC-1 (C), MiaPaCa-2 (D), and CFPAC-1 (E) cells treated with RSL3 at the indicated concentrations in the presence or absence of ferroptosis inhibitors (ferrostatin-1/Fer-1, 5 μM or desferrioxamine/DFO, 20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( F ) Lipid peroxidation of NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 (0.25 μM) for 2 h. (G) Transmission electron microscopy of NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 (2.5 μM). Scale bar: 2 μm or 500 nm. ( H ) Confocal imaging of Cu-probe and Mito-tracker in the NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1. Hoechst (blue) is used as a nuclear counterstain. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. Scale bar: 2 μm. ( I ) Western blot analysis of lysates from NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1. ( J ) Cell viability of NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1, followed by treatment with different doses of RSL3 or erastin. ( K ) PI staining of NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1, followed by treatment with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( L ) Western blot analysis of lysates from SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or SLC31A1 WT or SLC31A1 M154A plasmid. ( M ) PI staining of SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or SLC31A1 WT or SLC31A1 M154A plasmid, followed by treatment with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test.

    Journal: Redox Biology

    Article Title: Copper deprivation reprograms antioxidant defense to suppress ferroptosis via SLC7A11

    doi: 10.1016/j.redox.2026.104130

    Figure Lengend Snippet: Copper deprivation induced by SLC31A1 knockdown attenuates ferroptosis. ( A ) Cell viability of AsPC-1 cells treated with different doses of RSL3, ML162, ML210, or erastin in NC and SLC31A1 knockdown AsPC-1 cells. ( B ) Cell viability of AsPC-1 cells treated with different doses of CDDP, staurosporine, paclitaxel, bortezomib, JTC-801, or elesclomol-Cu in NC and SLC31A1 knockdown AsPC-1 cells. ( C-E ) Propidium iodide (PI) staining of NC and SLC31A1 knockdown AsPC-1 (C), MiaPaCa-2 (D), and CFPAC-1 (E) cells treated with RSL3 at the indicated concentrations in the presence or absence of ferroptosis inhibitors (ferrostatin-1/Fer-1, 5 μM or desferrioxamine/DFO, 20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( F ) Lipid peroxidation of NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 (0.25 μM) for 2 h. (G) Transmission electron microscopy of NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 (2.5 μM). Scale bar: 2 μm or 500 nm. ( H ) Confocal imaging of Cu-probe and Mito-tracker in the NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1. Hoechst (blue) is used as a nuclear counterstain. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. Scale bar: 2 μm. ( I ) Western blot analysis of lysates from NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1. ( J ) Cell viability of NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1, followed by treatment with different doses of RSL3 or erastin. ( K ) PI staining of NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or a vector encoding SLC31A1, followed by treatment with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( L ) Western blot analysis of lysates from SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or SLC31A1 WT or SLC31A1 M154A plasmid. ( M ) PI staining of SLC31A1 knockdown (shRNA#2) AsPC-1 cells transfected with a blank vector or SLC31A1 WT or SLC31A1 M154A plasmid, followed by treatment with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test.

    Article Snippet: Ferrostatin-1 (Fer-1) , Selleck Chemicals , S7243.

    Techniques: Knockdown, Staining, Transmission Assay, Electron Microscopy, Imaging, shRNA, Transfection, Plasmid Preparation, Western Blot

    Pharmacological induction of copper deprivation upregulates SLC7A11 and suppresses ferroptosis. ( A ) Western blot analysis of lysates from AsPC-1 cells treated with the indicated concentrations of TM for 24 h. ( B ) SLC7A11 mRNA level in AsPC-1 cells treated with TM at the indicated concentrations for 24 h. ( C ) Western blot analysis of lysates from AsPC-1 cells treated with TEPA at the indicated concentrations for 24 h. ( D ) SLC7A11 mRNA level in AsPC-1 cells treated with TEPA at the indicated concentrations for 24 h. ( E ) GSH level in the AsPC-1 cells treated with TM (50 μM) or TEPA (1 mM) for 24 h. Mean ± SD, n = 3. Statistical significance was determined using a one-way ANOVA test. ( F ) Cystine uptake level in the AsPC-1 cells treated with TM (50 μM) or TEPA (1 mM) for 24 h. Mean ± SD, n = 3. Statistical significance was determined using a one-way ANOVA test. ( G ) Cell viability of PDAC cells treated with RSL3 in the presence or absence of TM (50 μM) or TEPA (1 mM) for 24 h. ( H-J ) Propidium iodide (PI) staining of AsPC-1 (H), MiaPaCa-2 (I), and CFPAC-1 (J) cells treated with RSL3 at the indicated concentrations in the presence or absence of TM (50 μM) or TEPA (1 mM) with or without Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( K ) Lipid peroxidation of AsPC-1 cells treated with RSL3 (0.25 μM) in the presence or absence of TM (50 μM) or TEPA (1 mM) for 2 h. ( L ) Cell viability of KYSE-410, NCI–H1666, SW579, or OS-RC-2 cells treated with RSL3 at the indicated concentrations in the presence or absence of TM (50 μM) for 12 h.

    Journal: Redox Biology

    Article Title: Copper deprivation reprograms antioxidant defense to suppress ferroptosis via SLC7A11

    doi: 10.1016/j.redox.2026.104130

    Figure Lengend Snippet: Pharmacological induction of copper deprivation upregulates SLC7A11 and suppresses ferroptosis. ( A ) Western blot analysis of lysates from AsPC-1 cells treated with the indicated concentrations of TM for 24 h. ( B ) SLC7A11 mRNA level in AsPC-1 cells treated with TM at the indicated concentrations for 24 h. ( C ) Western blot analysis of lysates from AsPC-1 cells treated with TEPA at the indicated concentrations for 24 h. ( D ) SLC7A11 mRNA level in AsPC-1 cells treated with TEPA at the indicated concentrations for 24 h. ( E ) GSH level in the AsPC-1 cells treated with TM (50 μM) or TEPA (1 mM) for 24 h. Mean ± SD, n = 3. Statistical significance was determined using a one-way ANOVA test. ( F ) Cystine uptake level in the AsPC-1 cells treated with TM (50 μM) or TEPA (1 mM) for 24 h. Mean ± SD, n = 3. Statistical significance was determined using a one-way ANOVA test. ( G ) Cell viability of PDAC cells treated with RSL3 in the presence or absence of TM (50 μM) or TEPA (1 mM) for 24 h. ( H-J ) Propidium iodide (PI) staining of AsPC-1 (H), MiaPaCa-2 (I), and CFPAC-1 (J) cells treated with RSL3 at the indicated concentrations in the presence or absence of TM (50 μM) or TEPA (1 mM) with or without Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( K ) Lipid peroxidation of AsPC-1 cells treated with RSL3 (0.25 μM) in the presence or absence of TM (50 μM) or TEPA (1 mM) for 2 h. ( L ) Cell viability of KYSE-410, NCI–H1666, SW579, or OS-RC-2 cells treated with RSL3 at the indicated concentrations in the presence or absence of TM (50 μM) for 12 h.

    Article Snippet: Ferrostatin-1 (Fer-1) , Selleck Chemicals , S7243.

    Techniques: Western Blot, Staining

    SLC7A11 is essential for copper deprivation-mediated ferroptosis resistance. ( A ) NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC), SLC7A11 siRNA (siSLC7A11). Western blot analysis of lysates from the indicated AsPC-1 cells. ( B ) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). Western blot analysis of lysates from the indicated AsPC-1 cells treated with or without TM (50 μM) for 24 h. ( C ) NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). Propidium iodide (PI) staining of the indicated AsPC-1 cells treated with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( D ) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). PI staining of the indicated AsPC-1 cells treated with RSL3 at the indicated concentrations in the presence or absence of TM (50 μM) with or without Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( E ) NC and SLC31A1 knockdown AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). Lipid peroxidation of the AsPC-1 cells treated with RSL3 (0.25 μM) for 2 h. ( F ) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). Lipid peroxidation of the indicated AsPC-1 cells treated with RSL3 (0.25 μM) in the presence or absence of TM (50 μM) for 2 h. ( G ) PI staining of the NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 at the indicated concentrations in the presence or absence of BSO (500 μM) with or without Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( H ) PI staining images of the indicated AsPC-1 cells treated with or without BSO (500 μM) plus TM sulfate (50 μM) with RSL3 at the indicated concentrations with or without Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test.

    Journal: Redox Biology

    Article Title: Copper deprivation reprograms antioxidant defense to suppress ferroptosis via SLC7A11

    doi: 10.1016/j.redox.2026.104130

    Figure Lengend Snippet: SLC7A11 is essential for copper deprivation-mediated ferroptosis resistance. ( A ) NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC), SLC7A11 siRNA (siSLC7A11). Western blot analysis of lysates from the indicated AsPC-1 cells. ( B ) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). Western blot analysis of lysates from the indicated AsPC-1 cells treated with or without TM (50 μM) for 24 h. ( C ) NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). Propidium iodide (PI) staining of the indicated AsPC-1 cells treated with RSL3 at the indicated concentrations in the presence or absence of Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( D ) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). PI staining of the indicated AsPC-1 cells treated with RSL3 at the indicated concentrations in the presence or absence of TM (50 μM) with or without Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( E ) NC and SLC31A1 knockdown AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). Lipid peroxidation of the AsPC-1 cells treated with RSL3 (0.25 μM) for 2 h. ( F ) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). Lipid peroxidation of the indicated AsPC-1 cells treated with RSL3 (0.25 μM) in the presence or absence of TM (50 μM) for 2 h. ( G ) PI staining of the NC and SLC31A1 knockdown AsPC-1 cells treated with RSL3 at the indicated concentrations in the presence or absence of BSO (500 μM) with or without Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. ( H ) PI staining images of the indicated AsPC-1 cells treated with or without BSO (500 μM) plus TM sulfate (50 μM) with RSL3 at the indicated concentrations with or without Fer-1 (5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test.

    Article Snippet: Ferrostatin-1 (Fer-1) , Selleck Chemicals , S7243.

    Techniques: Knockdown, shRNA, Transfection, Western Blot, Staining

    SLC7A11 is essential for copper deprivation-mediated ferroptosis resistance. ( A ) Vector or flag-SLC7A11 overexpressed AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). Western blot analysis of lysates from the indicated AsPC-1 cells. ( B ) AsPC-1 cells were transfected with a vector or a plasmid encoding Flag-SLC7A11 and then treated with TM (50 μM) for 24h. Western blot analysis of lysates from the indicated AsPC-1 cells. ( C ) NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11) with or without transfection with a blank vector or a vector encoding SLC7A11. PI staining of indicated AsPC-1 cells treated with RSL3 (0.25 μM) in the presence or absence of Fer-1 (2.5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. Scale bar: 50 μm. ( D ) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11) with or without transfection with a blank vector or a vector encoding SLC7A11. PI staining images of indicated AsPC-1 cells treated with RSL3 (0.25 μM) or TM (50 μM) in the presence or absence of Fer-1 (2.5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. Scale bar: 50 μm.

    Journal: Redox Biology

    Article Title: Copper deprivation reprograms antioxidant defense to suppress ferroptosis via SLC7A11

    doi: 10.1016/j.redox.2026.104130

    Figure Lengend Snippet: SLC7A11 is essential for copper deprivation-mediated ferroptosis resistance. ( A ) Vector or flag-SLC7A11 overexpressed AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11). Western blot analysis of lysates from the indicated AsPC-1 cells. ( B ) AsPC-1 cells were transfected with a vector or a plasmid encoding Flag-SLC7A11 and then treated with TM (50 μM) for 24h. Western blot analysis of lysates from the indicated AsPC-1 cells. ( C ) NC and SLC31A1 knockdown (shRNA#2) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11) with or without transfection with a blank vector or a vector encoding SLC7A11. PI staining of indicated AsPC-1 cells treated with RSL3 (0.25 μM) in the presence or absence of Fer-1 (2.5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. Scale bar: 50 μm. ( D ) AsPC-1 cells were transfected with non-targeting scrambled siRNA (siNC) or SLC7A11 siRNA (siSLC7A11) with or without transfection with a blank vector or a vector encoding SLC7A11. PI staining images of indicated AsPC-1 cells treated with RSL3 (0.25 μM) or TM (50 μM) in the presence or absence of Fer-1 (2.5 μM) or DFO (20 μM) for 6 h. Quantification of PI-positive cells was shown. Mean ± SD, n = 3. Statistical significance was determined using a two-way ANOVA test. Scale bar: 50 μm.

    Article Snippet: Ferrostatin-1 (Fer-1) , Selleck Chemicals , S7243.

    Techniques: Plasmid Preparation, Transfection, Western Blot, Knockdown, shRNA, Staining